Position in NTRA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,337,705
+$662,539 QoQ
Shares Held
4,928
+46.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#412
of 847 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NewEdge Wealth, LLC holds $44,743,682 across 11 Diagnostics & Research names. NTRA ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
|
51,943 | $27,508,493 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
10,697 | $5,363,047 | |
| 3 | DHR |
Danaher Corp /De/
|
23,171 | $4,413,612 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
5,843 | $3,075,988 | |
| 5 | ICLR |
Icon PLC
|
8,345 | $1,449,609 | |
| 6 | NTRA |
Natera, Inc.
This page
|
4,928 | $1,337,705 | |
| 7 | A |
Agilent Technologies, Inc.
|
5,030 | $668,134 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
1,091 | $247,427 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,337,705 | 4,928 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $675,166 | 3,376 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $609,608 | 2,661 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $372,323 | 2,313 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||